XML 86 R73.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity - Warrants (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Mar. 24, 2025
Mar. 19, 2024
May 15, 2023
Number of Other than Options          
Outstanding and exercisable, beginning balance (in shares) 111,606        
Issued (in shares) 163,957        
Expired/Forfeited (in shares) (11,606)        
Outstanding, ending balance (in shares) 263,957 111,606      
Exercisable (in shares) 163,957        
Weighted Average Exercise Price          
Outstanding and exercisable, beginning balance (in dollars per share) $ 16.71        
Issued (in dollars per share) 6.52        
Expired/Forfeited (in dollars per share) 31.46        
Outstanding, ending balance (in dollars per share) 9.73 $ 16.71      
Exercisable, ending balance (in dollars per share) $ 6.52        
Weighted Average Remaining Contractual Life (in Years), Outstanding 8 years 11 months 15 days 8 years 5 months 15 days      
Weighted Average Contractual Life (in Years), Exercisable 9 years 3 months 21 days        
Other disclosures          
Purchaseable stock 2,368,072 1,979,413 2,379,508    
Compensation expense $ 470,000 $ 220,000      
Number of shares vested 28,770        
Halston License          
Other disclosures          
Purchaseable stock   100,000      
Warrants outstanding, exercise price (in dollars per share)   $ 15      
Warrants          
Other disclosures          
Purchaseable stock       18,293  
Compensation expense $ 0        
Warrants | Halston License          
Other disclosures          
Warrant term         10 years
Contra-revenue related to warrants held by licensee $ 40,000.00 $ 30,000.00      
Number of shares vested 0        
Warrants | Target price          
Stockholders' Equity          
Expiration period 5 years        
Warrants | Target revenue          
Stockholders' Equity          
Expiration period 10 years